Markt geschlossen -
Andere Börsenplätze
|
Nachbörslich 19:13:42 | |||
4.95 EUR | -0.72% | 4.936 | -0.28% |
07.05. | AstraZeneca-Ziel angehoben; Antofagasta gesenkt | AN |
03.05. | AIB-GRUPPE : Stärkeres Umsatzwachstum und günstige Risikokosten |
ETFs investiert in AIB Group plc
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
0,24% | 3 M€ | +9.95% | - | |
0,21% | 5 M€ | +10.09% | - | |
0,21% | 14 M€ | +5.66% | - | |
0,10% | 33 M€ | +1.79% | - | |
0,08% | 6 M€ | -.--% | ||
0,06% | 6 M€ | -.--% | - | |
0,03% | 10 M€ | -3.35% | - | |
0,01% | 786 M€ | -.--% | ||
0,01% | 23 M€ | -.--% | - | |
0,01% | 1 166 M€ | +0.26% | ||
0,01% | 607 M€ | +0.05% | ||
0,01% | 284 M€ | -.--% | ||
0,01% | 45 M€ | 0.00% | - | |
0,01% | 391 M€ | +8.67% | - | |
0,00% | 7 M€ | +0.11% | - | |
0,00% | 34 M€ | +3.77% | - | |
0,00% | 105 M€ | +3.54% | - | |
0,00% | 234 M€ | +2.60% | - | |
0,00% | 34 M€ | +8.24% | - | |
0,00% | 306 M€ | +5.68% | - | |
0,00% | 39 M€ | +5.63% | - | |
0,00% | 54 M€ | +0.54% | - | |
0,00% | 29 M€ | -2.25% | - | |
0,00% | 146 M€ | -2.53% | - | |
0,00% | 25 M€ | -3.22% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+27.58% | 13 Mrd. | |
+16.85% | 571 Mrd. | |
+14.02% | 301 Mrd. | |
+18.85% | 252 Mrd. | |
+25.10% | 216 Mrd. | |
+21.08% | 183 Mrd. | |
+25.17% | 170 Mrd. | |
+10.02% | 162 Mrd. | |
+6.57% | 146 Mrd. | |
-14.86% | 131 Mrd. |
- Börse
- Aktien
- A2DW7N Aktie
- ETFs AIB Group plc